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Abstract
The circadian clock is an endogenous cycle that temporally coordinates physiological and
behavioural processes with the Earth’s rotation about its axis. This molecular clock has been
proposed to control multiple fundamental biological processes such as metabolism, cell cycle and
proliferation-processes in which abnormalities have been shown to be tumourigenic.
Epidemiological studies suggest shift workers are at an increased risk for various cancers including
breast and colorectal cancer. Colorectal cancer is initiated by mutations to the Adenomatous
Polyposis Coli (APC) gene in which loss of heterozygosity results in constitutive Wnt signaling,
resulting in increased cellular proliferation. Previous work done in the lab has shown that APCmin/+
mice that lack all circadian behavioural and physiological rhythms due to a mutation in the core,
non-redundent clock gene, BMAL1, produce two times the number of intestinal tumours. I
hypothesized that that the BMAL1-/--dependent increase in tumourigenesis was due to an intrinsic
intestinal epithelial mechanism. To test this, immunohistochemistry was used to characterize 3
mechanisms of intestinal biology: 1. circadian clock status, 2. cell production and Wnt signalling
and 3. inflammation. This data revealed that clock mutant animals exhibit a slight decrease in
intestinal turnover suggesting an abnormality in tissue homeostasis. The role the intestinal clock
specifically plays in tumourigenesis was investigated using a conditional knockout of BMAL1 in
only the intestinal epithelium. The conditional knock out mice exhibited increased tumour
initiation; however, tumour growth and progression were unaffected. Additionally, prolonged
inflammation further increased tumour initiation events in both wild type and conditional knock
out animals but is not implicated in BMAL1-/- induced tumour growth. Together, these data suggest
the intrinsic intestinal circadian clock supresses tumour initiation.
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Chapter 1: Introduction

1

1.1 Circadian rhythms
Circadian rhythms are recurring 24-hour physiological changes that coordinate biological
and behavioural processes with the Earth’s rotation1. The ability of an organism to coordinate their
metabolism and other physiological processes is thought to optimize fitness by allowing
complementary processes to take place at the same time; for example, having DNA damage repair
processes highest during daytime when risk for Ultraviolet DNA damage is greatest2. Additionally,
it can also prevent incompatible processes from occurring simultaneously, such as inhibiting DNA
synthesis from occurring at the same time as high levels of inflammation and genotoxic stress as
increased levels of inflammation can induce DNA damage3.
There are 4 main characteristic that define circadian rhythms: (1) they have a 24 hour
period, meaning the rhythms recur every 24 hours, (2) they are free-running, meaning the rhythms
will exist in the absence of external stimuli, (3) they are entrainable; although they do not require
external stimuli, the rhythms can be shifted due to light/feeding cues, and (4) they are temperature
compensated, meaning the period will remain unaltered over a wide range of temperatures1. These
four characteristics distinguish circadian rhythms from basic environmental responses and other
types of rhythms as it ensures the rhythms are a product of an internal time-keeping mechanism1.
This internal mechanism is known as the circadian clock and is present in a wide variety of
organisms4–7.

1.2 Circadian clock
The circadian clock is an endogenous cycle that temporally controls physiological and
behavioural processes to anticipate 24 hour environmental changes1. This molecular network of
genes and proteins is responsible for producing circadian rhythms. Over 40% of protein-coding
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genes in mice have been proposed to undergo circadian oscillations in transcription in a tissue
specific manner8. Circadian oscillations are controlled by a network of autoregulatory
transcription-translation feedback loops. In mammals, the core circadian clock genes consist of the
activators, CLOCK (CLK1,2), its paralog NPAS2, and BMAL1 (BMAL1-2), and their repressors,
PERIOD (PER1,2,3) and CYRPTOCHROME (CRY1,2). CLOCK/NPAS2 and BMAL1
heterodimerize and promote the transcription of PER and CRY by binding to E-boxes located in
their promoters. PER and CRY accumulate and heterodimerize to inhibit the activity of CLOCK
and BMAL1 resulting in a new cycle. There is also a secondary feedback loop involving REVERB and ROR, which are a BMAL1 repressor and activator respectively, that further control
BMAL1 rhythmicity9. BMAL1 is the only non-redundant component of the circadian clock,
therefore mutations in this gene would eliminate circadian function in the cell. A schematic of the
circadian clock mechanism is presented in Figure 1.1.
The coordination of all the tissue clocks throughout the body is important for proper
function and timing of various processes. In mammals, this coordination is accomplished through
a hierarchical system in which the master pacemaker lies within the suprachiasmatic nucleus
(SCN) located in the hypothalamus and is entrained by light cues received from the retina. Light
is detected by a subset of intrinsically photosensitive retinal ganglion cells (ipRGC) that make up
the retinal-hypothalamic tract and project directly to the SCN. When stimulated, the ipRGCs
release glutamate which trigger a cascade of molecular events in SCN neurons altering clock gene
expression and thus resetting the cycle9,10. The SCN provides output to peripheral tissue clocks,
through neuronal and hormonal signals, to synchronize other tissue clocks to the proper phase11,12.
The SCN achieves synchrony through the hypothalamic-pituitary-adrenal axis via glucocorticoid
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secretion13,14. This allows for coordination of systemic rhythms with external stimuli thereby
allowing for adaptation to ever changing environmental factors.
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Ror

CLOCK
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ROR
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Figure 1.1: The molecular circadian clock mechanism modified from Gaucher et al15.
BMAL1 and CLOCK heterodimerize and bind to E-boxes throughout the genome promoting the
transcription of PER and CRY. PER and CRY are translated in the cytoplasm, heterodimerize and
move back into the nucleus where they inhibit BMAL1:CLOCK activity. There is a secondary
loop involving REV-ERB and ROR which act as a BMAL1 transcriptional repressor and
activator respectively which allow for further control of BMAL1 rhythmicity. This molecular
mechanism is present in all cells of the body and is conserved amongst many organisms.

1.3 Wnt signaling in the intestine and implications in colorectal cancer
The mammalian intestine is made up of simple epithelium organized into outward
projections, known as villi, and invaginations, known as crypts of Lieberkuhn16. The villi are
responsible for the absorption of nutrients and crypts house the intestinal stem cells (ISC) which
are responsible for tissue homeostasis and repair16. ISCs produce transit-amplifying cells that
eventually divide and differentiate into all intestinal epithelial cells including enterocytes,
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enteroendocrine cells, goblet cells and Paneth cells16. The maintenance of the ISCs and their rapid
proliferative ability is crucial for proper intestinal homeostasis as this tissue experiences constant
damage from mechanical strain of moving nutrients through the digestive tract, exposure to
digestive enzymes, and bacteria from the microbiota; therefore this tissue undergoes complete
cellular turnover every 4-5 days17. The maintenance of these resident ISCs is sustained by the Wnt
signaling pathway, where the Wnt ligand is secreted by both mesenchymal telocytes surrounding
the crypt and villi, and epithelial Paneth cells found within the crypt18.
When the Wnt ligand is not present, such as in the villi, APC complexes with AXIN and
GSK3 to form a destruction complex that phosphorylates 𝛽-catenin and marks it for proteasomal
degradation19. Whereas, in the crypts, where there is active Wnt secretion, Wnt binds to the
transmembrane receptor FRIZZLED and its co-receptor LRP, and through a sequence of molecular
events, it sequesters and disrupts the APC/AXIN/GSK3 destruction complex which allows for 𝛽catenin accumulation. 𝛽-catenin is then able to translocate into the nucleus where it acts as a
transcription factor for Wnt target genes19 involved in cell proliferation, such as the oncogene cMYC, and stem cell maintenance genes such as LGR520. A schematic of Wnt signaling is presented
in Figure 1.2. Mutations in the Wnt signaling pathway occur in up to 95% of all colorectal
cancers21, with ~80% of mutations occurring specifically in the Wnt pathway negative regulator,
Adenomatous Polyposis Coli (APC) gene22,23.
Colorectal cancer (CRC) is commonly defined as a step-wise accumulation of sequential
mutations of specific cell cycle regulatory genes, including APC and K-ras, and tumour
suppressors, such as p53, as originally proposed by Fearon and Volgenstein24,25 (Figure 1.3). The
order in which the mutations occur is not as important as the simple accumulation of these
mutations, however trends are observed in the genes required for initiation of tumourigenesis24. In
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humans, Familial Adenomatous Polyposis (FAP) is an autosomal-dominant hereditary condition
in which an individual possesses a heterozygous mutation in the APC gene in which this copy
produces a non-functional, truncated protein26. In tissues with high cellular turnover, such as the
digestive tract, spontaneous loss of heterozygosity of the remaining functional copy of the APC
gene occurs frequently and removes the negative regulation of Wnt signaling. Therefore, it is
thought to be one of the first tumour initiating steps, resulting in hyperproliferation24. FAP
individuals develop numerous polyps or adenomas throughout their lifetime, many of which occur
in the large intestine and colon, and if left untreated, can progress into carcinomas. This highlights
the importance of proper APC function in suppressing tumour initiating events.
This type of inherited cancer predisposition is easily modeled in mice using an APC
mutated allele denoted APCmin (multiple intestinal neoplasia). These mice similarly only have one
functional copy of the APC gene and thus also undergo spontaneous loss of heterozygosity
resulting in numerous adenomas throughout their digestive tract. Due to this model’s resemblance
to the human phenotype, research has begun looking into factors that contribute to the development
and progression of CRC25. One emerging area of research involves the role of the circadian clock
in CRC tumourigenesis, as epidemiological studies have suggested individuals undergoing shift
work and prolonged circadian disruption were at a higher risk for developing CRC and other
cancers27,28.
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Target
genes

Figure 1.2: Schematic of Wnt OFF and ON signaling modified from Jansson et al29. In intestinal
villi, when Wnt signaling is off, APC forms a destruction complex with AXIN and GSK3 which
phosphorylates 𝛽-catenin marking it for degradation by the proteasome preventing Wnt target
genes from being transcribed. In the intestinal crypts when Wnt signaling is on, the APC
destruction complex is sequestered and inactivated allowing for 𝛽-catenin accumulation and
translocation into the nucleus where it acts as a transcription factor for Wnt target genes such as cMYC and LGR5.
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Figure 1.3: Proposed genetic model for colorectal cancer. Colorectal tumourigenesis is believed
to progress through a series of genetic mutations. APC mutations are generally observed early on
in colorectal cancer development as they promote hyperproliferation through constitutive Wnt
signaling. Mutations to the proto-oncogene K-RAS on their own show mild proliferative
phenotypes but if they occur following an APC mutation they often progress to carcinomas30. Loss
of tumour suppressor genes, such as p53, reduces the cell’s ability to control division which allows
for increased tumour growth. Finally, additional mutations are required for cancer cell invasion
and metastasis. (adapted from Fearon and Volgenstein24)

1.4 Circadian clock and cancer
Epidemiological studies have suggested that shift-workers or individuals who undergo
prolonged circadian disruption are at a higher risk for various cancers such as breast28, colon27 and
lung cancer31 but it is unclear whether this relationship is causal or correlational. Nonetheless, the
circadian clock has been shown to control many fundamental biological processes, many of which,
when disrupted, have potential implications in cancer initiation and progression. For example, one
study found that the circadian clock plays a role in maintaining mitotic rhythms in transit
amplifying cells within hair follicles32. Through rhythmic inhibitory phosphorylation of CDC2,
this proposed circadian regulation coordinates G2/M progression with genotoxic stress
responses32. This would allow for DNA repair to occur while cells are reaching the G2/M DNA
damage checkpoint to mediate efficient and timely progression into mitosis. Circadian clock
8

disruption could result in abnormal regulation of this G2/M gating and changes to DNA damage
repair timing which could contribute to mutations and tumour formation. A complementary study
investigated the nucleotide excision repair system in mice subjected to specific time of day UV
irradiation. They also observed circadian changes in the DNA damage repair process, specifically
due to rhythmic expression of XPA, the rate limiting subunit of nucleotide excision repair2. When
XPA levels were at their minimum, mice were more susceptible to UV radiation and produced
more skin cancer compared to those irradiated at XPA’s peak2. The circadian clock could
coordinate XPA levels with the daytime when the risk of UV damage is highest to reduce
susceptibility to mutations. Therefore, clock disruption, thereby disruption of proper DNA damage
repair timing could increase mutation risk and thus affect cancer progression.
Circadian disruption has also been associated with altered glucose metabolism leading to
diabetes due to deregulated insulin secretion in pancreatic 𝛽-cells33. Additionally, it was found that
indirect circadian disruption caused cells to increase their glucose consumption which has been
associated with increased cellular growth34. Therefore, clock disruption can perturb metabolic
oscillations which could favour growth of cancer cells. Finally, inflammation has been shown to
be altered in response to disruptions of the circadian clock. One study showed increased infiltration
of T-helper 17 cells in intestinal epithelium in response to loss of the circadian clock components,
PER1/235. This demonstrates that clock disruption can affect inflammatory cell abundance in
tissues, potentially increasing inflammation and production of reactive oxygen species (ROS)
thereby increasing the risk for DNA damage that could lead to cancer initiation and progression.
Additionally, immune cell cytokine production and secretion is rhythmic and abnormal in
circadian clock disrupted animals36. Therefore disruption of the clock may increase cytokine
secretion which can directly cause cells to proliferate potentially contributing to tumour growth37.
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Collectively, these studies demonstrate the circadian clock mediates oscillations of various cellular
and systemic processes, including the cell cycle, DNA damage response, metabolism and
inflammation–processes which can be pro-tumourigenic when functioning abnormally.
Since the circadian clock has been implicated in processes that are pro-tumourigenic when
deregulated, along with increased cancer incidence among circadian disrupted individuals,
researchers have begun investigating how exactly the circadian clock affects tumourigenesis.
Relevant to this thesis, one study examined the role the PER2 gene plays in colorectal cancer.
Using human colon cancer cell lines, down regulation of PER2 using siRNA increased 𝛽-catenin,
cyclin D and cell proliferation38. They then examined the effects of PER2 loss on colorectal cancer
in vivo using PER2 mutant mice on an APCmin/+ background and observed the PER2 mutants
showed a two-fold increase in small intestinal adenomas and a 2-3 fold increase in colon polyps38.
Again, PER2 loss in vivo showed increased levels of 𝛽-catenin and cyclin D suggesting PER2 acts
as a tumour suppressor by regulating 𝛽-catenin levels, preventing excessive Wnt signaling and
proliferation.
The PER2 gene has also been implicated in tumour progression through its proposed role
in DNA damage-induced apoptosis. PER2 mutant mice subjected to radiation exhibited increased
incidence of spontaneous tumour formation due to decreased p53 levels and decreased apoptosis
as well as arrhythmic c-MYC expression39. Additionally, overexpression of PER2 in culture using
Lewis lung carcinoma and mammary carcinoma cell lines caused decreased cellular proliferation
and increased apoptosis due to elevated p53 levels40 complementary to the previously mentioned
study. Collectively, these studies suggest that PER2 mediates components of the Wnt signaling
pathway as well as aspects of apoptosis, which when lost, promote tumourigenesis. Although PER
paralogs are components of the core circadian clock mechanism, these studies only use single
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mutant mice therefore all the animals still have proper circadian rhythms and behaviours.
Consequently, these results can only be understood as a product of PER function rather than
circadian function.
There are other studies that have examined the effect of environmental photoperiod
disruption on tumourigenesis. For example, one found that mice subjected to prolonged circadian
disruption through photoperiod disturbance had increased tumour progression and decreased
survival with lung cancer as well as in mice after a Glasgow osteosarcoma xenograph41. This
suggests that there may be a circadian component to cancer initiation and progression rather than
gene specific effects. Additionally, researchers have examined the effect of BMAL1 in various
cancer types as this is the only non-redundant component of the clock and loss of BMAL1
eliminates both behavioural and biological circadian rhythms. The loss of BMAL1 has been shown
to increase tumourigenesis in lung and pancreatic cancer due to reduced levels of p53 and increased
c-MYC levels which is paradoxically similar to the results found using the PER mutants42,43; one
would expect mutations in positive and negative regulators of clock function to produce opposite
phenotypes. Moreover, other clock components have shown anti-cancer effects including REVERB, the negative regulator of BMAL1 and part of the secondary loop of the clock. Recently, REVERB agonists have been shown to inhibit and reduce growth of both glioblastoma and small cell
lung cancer44,45. In both cases, REV-ERB was shown to inhibit autophagy, a mechanism cancer
cells utilize in order to circumvent senescence and meet metabolic demands for proliferation46.
Collectively, these studies demonstrate that disruption of the circadian clock through photoperiod
or gene manipulation can affect 𝛽-catenin levels, c-MYC levels, p53 induced apoptosis, and
autophagy, all of which have implication in cancer.
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Although there have been many studies suggesting the circadian clock acts as a tumour
suppressor, some of which are summarized above, there have been quite a few studies that have
provided contradictory results. One study attempted to validate earlier PER research mentioned
previously by testing healthy and irradiated PER1 and PER2 mutants. They actually found that
PER mutations alone do not increase risk of tumours, in opposition to earlier findings47. This study
advantageously used a backcrossed congenic strain of mice rather than mice of a mixed genetic
background, a major source of error in the previously mentioned study39. Another study from the
same first author examined CLOCK mutant mice subjected to irradiation and again, observed no
differences in cancer incidence between wildtype and CLOCK mutants48, further suggesting
mutations to circadian clock components do not make animals more tumour prone after irradiation.
These studies utilize only single mutants therefore these animals still exhibit normal circadian
rhythms and due to redundancy in clock genes, these results are therefore, again, gene specific
rather than a consequence of abnormal circadian biology.
Additionally, there is some research that shows the circadian clock actually promotes
tumour initiation and progression in certain cancer types. For example, it was found that in Acute
Myeloid Leukemia (AML), both BMAL1 and CLOCK are required for leukemia stem cell
growth49. Disruption of these genes genetically results in impaired cancer cell proliferation and
increased differentiation thereby decreasing severity of AML. Another study found that loss of
BMAL1 in the skin also decreases cutaneous squamous tumour incidence and size on mouse tail
tissue due to decreased number of cancer-initiating cells and increased expression of tumour
suppressors50. Furthermore, elevated BMAL1 levels has been shown to increase breast cancer
metastasis in vitro by upregulation of MMP9, a member of the matrix metalloproteinase family
involved in degradation of tumour extracellular matrix and tumour cell invasion thus promoting
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tumour progression51. Finally, in p53 mutated tumour prone mice, loss of both CRY1/2 actually
exhibits a protective advantage and prevents early onset cancer, extending their lifespan ~50%52.
They observed increased levels of pro-apoptotic cytokines, such as TNF𝛼, promoting extrinsic
apoptosis thus slowing cancer progression52,53. This varies significantly from the previously
mentioned PER studies in which cancer progression in PER mutants were attributed to decreased
p53 levels.
Together, these studies demonstrate the circadian clock and cancer field of research
contains many complementary and contending results providing evidence to support the circadian
clock acting as a tumour suppressor whereas others show certain cancers actually require clock
function (studies mentioned are summarized in Table 1.1). This creates somewhat of a paradox,
leaving the role the circadian clock plays in cancer progression an unanswered question.
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Table 1.1: Role of the circadian clock in various cancer types

PHOTOPERIOD
DISRUPTION
PROMOTES
CANCER

CLOCK GENE
DISRUPTION
PROMOTES
CANCER

CLOCK GENE
AGONISTS
SUPRESS CANCER

CLOCK GENE
DISRUPTION
SUPRESSES
CANCER

CLOCK GENE
DISRUPTION HAS
NO EFFECT ON
CANCER

TYPE OF
CANCER

EXPERIMENT
TYPE

Glasgow
Osteosarcoma

In vivo xenograph
model

Liver Cancer

SUMMARY

REF.

Photoperiod disruption increased
tumour progression post xenograph

41

In vivo mouse
model

Photoperiod disruption increased
tumour incidence post exposure to liver
damaging agent

54

Lung Cancer

In vivo mouse
model

Photoperiod disruption increased
tumour burden in susceptible mice

42

Lymphoma

In vivo genetic
mouse model

PER2 mutant mice exhibited increased
spontaneous tumour formation post
irradiation

39

Liver Cancer

In vivo genetic
mouse model

Loss of PER2 increases tumour
incidence

55

Lung Cancer

In vivo genetic
mouse model

Loss of BMAL1 and PER2 increased
cancer progression

42

Pancreatic
Cancer

In vitro and in
vivo xenograph
model

Loss of BMAL1 promotes cancer
proliferation and invasion

43

Colorectal
Cancer

In vivo genetic
mouse model

PER2 loss increased tumour formation
and cell proliferation in APCmin/+ mice

38

Glioblastoma

In vitro and in
vivo xenograph
model

REV-ERB agonists prevent and inhibit
tumour growth

44,45

Small Cell
Lung Cancer

In vitro and in
vivo xenograph
model

REV-ERB agonists prevent and inhibit
tumour growth

56

Squamous
tumours

In vivo genetic
mouse model

BMAL1 loss decreased number of
tumours; PER1/2 loss increased tumour
number

50

Acute
Myeloid
Leukemia

siRNA xenograph
model

Loss of CLOCK and BMAL1 promotes
cancer cell differentiation and impairs
proliferation

49

Breast Cancer

In vitro model

Overexpression of BMAL1 promotes
breast cancer cell metastasis

51

Lymphoma

In vivo genetic
and xenograph
mouse model

Loss of CRY1/2 in p53 mutant mice
decreased early onset cancer and
extended life span

52,57

Lymphoma

In vivo mouse
model

Loss of PER1, PER2 and CLOCK has
no effect on tumour formation post
irradiation

47,48
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1.5 Hypothesis and Specific aims
Previous work performed by Malika Nunes, a MSc student in our lab, found that APCmin/+ mice
tumour number is BMAL1-dependent. APCmin/+; BMAL1+/- mice were backcrossed for >6
generations to produce a congenic strain and remove any genetic background effects noted in the
above studies. From the 4 genotypically different littermates analyzed, both control mice (APC+/+;
BMAL1+/+) and BMAL1 mutant (APC+/+; BMAL1-/-) mice produced no intestinal tumours
demonstrating loss of BMAL1 alone is unable to promote tumour formation. However, the loss of
BMAL1 in mice predisposed to intestinal tumours (APCmin/+; BMAL1-/-) produced two times the
number of tumours than tumour prone BMAL1 wildtype mice (APCmin/+; BMAL1+/+) suggesting
BMAL1 acts as a tumour suppressor in genetically-sensitized animals.

The APCmin/+-driven tumours originate from the intestinal epithelium58 but this does not mean
the loss of circadian control in the epithelium is solely responsible for the increased tumourigenesis
in the APCmin/+; BMAL1-/- mice. There is a possibility that the epithelium is responding to signals
from surrounding tissues causing it to over-proliferate. I hypothesized that the BMAL1-/--dependent
increase in tumours is due to an intrinsic epithelial mechanism since the circadian clock has been
suggested to regulate fundamental molecular processes such as the cell cycle, DNA damage
response and metabolism.
To test this hypothesis, this project had two main objectives:
1. Investigate three characteristics of intestinal biology that could contribute to increased
tumourigenesis in the BMAL1 KO animals using immunohistochemistry and
immunofluorescence on APCmin/+ BMAL1+/+ and APCmin/+ BMAL1+/+ mice.
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a. Circadian status of healthy and tumourous intestinal tissue: Investigate a tissue
intrinsic mechanism by assessing circadian activity at the translational level
through immunofluorescence using an anti-REV-ERB antibody at multiple
timepoints throughout the day. REV-ERB is a negative regulator of BMAL1 and
part of the secondary loop of the circadian clock. REV-ERB was analyzed
specifically because recent studies have shown REV-ERB acts as a tumour
suppressor by inhibiting autophagy, a mechanism used by cancer cells to overcome
senescence and continue dividing44,45. Since BMAL1 is a positive regulator of REVERB transcription, BMAL1 mutant animals should theoretically have lower levels
of REV-ERB and would thereby lose this anti-autophagy ability allowing for
tumour progression.
b. Cell production and Wnt signaling: Investigate the tissue intrinsic mechanism of
cell production indirectly through analysis of crypt morphology, using crypt length
and density, to assess cellular turnover. Additionally, Wnt signaling was analyzed
using immunohistochemistry staining for 𝛽-catenin, the signal transducer of the
Wnt signaling pathway. The Wnt ligand has been proposed to be rhythmically
secreted by Paneth cells in the intestine59 therefore loss of the circadian clock could
affect the regulation of Wnt secretion and potentially increase proliferation and risk
of tumourigenesis.
c. Inflammation: Investigate systemic contribution of inflammation to tumourigenesis
by staining for myeloperoxidase, which marks neutrophils, in healthy and
tumourous intestinal tissue. Neutrophils are a part of the initial acute inflammatory
response and produce ROS. Chronic or high levels of inflammation can expose
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surrounding cells to excessive oxidative stress3 and cytokine production60,
potentially increasing the risk for DNA mutations and cell proliferation respectively
thus influencing tumourigenesis.
2. Investigate, specifically, the role of the intestinal circadian clock in tumour initiation and
progression. A conditional knockout (CKO) of BMAL1 in only the intestinal epithelium
was made on the APCmin/+ genetic background. These mice were analyzed for tumour
incidence by looking at number, location and size of tumours in the small intestine to assess
whether the intestinal circadian clock alone is able to supress any aspects of tumourigenesis
in tumour prone mice.
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1.6 Materials and Methods:
Animals and housing
Mice were housed in 12 hour light, 12 hour dark photoperiod with ad libitum feeding. This
study strictly adhered to all University of Windsor Animal Care Committee (ACC) guidelines from
AUPP17-21. Mice were weaned at 21 days old and genotyped from tail clips using the following
PCR primers:
Table 1.2: Genotyping Primers
GENE

COMMON
FORWARD PRIMER
(5’à3’)

WILDTYPE REVERSE
PRIMER (5’à3’)

APC

TTCCACTTTGGCATA
AGGC

GCCATCCCTTCACGT
TAG

TTCTGAGAAAGACA
GAAGTTA

BMAL1

GCCCACAGTCAGAT
TGAAAAG

CCCACATCAGCTCAT
TAACAA

GCCTGAAGAACGAG
ATCAGC

GCCTTCTCCTCTAGG
CTCGT
ACTGGAAGTAACTTT
ATCAAACTG

TATAGGGCAGAGCTG
GAGGA
CTGACCAACTTGCTA
ACAATTA

AGGCAAATTTTGGTG
TACGG

VILCRE
BMAL
FLOX

MUTANT REVERSE
PRIMER (5’à3’)

N/A

Creation of BMAL1 KO strain on APCmin/+ genetic background
Male APCmin/+ mice (C57BL/6J-ApcMin/Jackson Lab Stock number 002020) were
backcrossed to female BMAL1+/- mice (B6.129Arntltm1Bra/Jackson Lab Stock 009100) for >6
generations to produce a congenic strain. The offspring of this cross produced the APCmin/+ + BMAL1
wildtype mice (APCmin/+; BMAL1+/+) and APCmin/+ + BMAL1 mutant mice (APCmin/+; BMAL1-/-) used
for immunofluorescence and immunohistochemistry.
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Creation of BMAL1 CKO strain on APCmin/+ genetic background

Vilcre/+ (B6.Cg-Tg(Vil1-cre)1000Gum/Jackson Lab Stock Number. 021504) males were
bred with BMAL1fl/fl (B6.129S4(Cg)-ArntltmWeit/Jackson Lab Stock Number. 007668) females to
obtain Vilcre/+; BMAL1fl/+ offspring. The Vilcre/+; BMAL1fl/+ mice were then crossed with BMAL1fl/fl
mice to produce Vilcre/+; BMAL1fl/fl conditional knockout mice.

APCmin/+ (C57BL/6J-ApcMin/J/Jackson Lab Stock Number: 002020) male mice were bred
with BMALfl/fl females to obtain APCmin/+; BMAL1fl/+ offspring. The APCmin/+; BMAL1fl/+ male
mice were then crossed with BMALfl/fl female mice to produce APCmin/+; BMAL1fl/fl progeny.
Vilcre/+; BMAL1fl/fl females were crossed, when needed, to APCmin/+; BMAL1fl/fl males to produce
the experimental group, APCmin/+; Vilcre/+; BMAL1fl/fl, and the control littermates, APCmin/+; Vil+/+;
BMAL1fl/fl.

Tissue Collection
Animals were sacrificed via CO2 asphyxiation followed by cervical dislocation. The
abdominal cavity was opened, and the intestine was removed. The intestine was cut into 3 equal
segments. An 18-gauge needle was inserted into the posterior end of the segment and the intestine
was flushed using cold 1XPBS. The flushings were placed in a 50mL falcon tube and stored at 80˚C for later analysis.
For samples used for later RNA analysis, the intestinal segment was then cut length wise
to expose villi. A microscope slide was gently run along the villi to obtain a villus scraping. A
piece of liver was also collected from each mouse. The villus scrapings and liver samples were
then placed into RNAlater and stored in the -80˚C freezer until RNA extraction was performed.
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For intestinal samples used for tumour quantification, the intestine was cut lengthwise, and
a labelled 25-gauge needle was inserted to the proximal portion of the segment to identify it as the
proximal, medial or distal segment. The intestine was then placed into 4% PFA for 2 hours or 24
hours. Intestines were washed 3 times with 1XPBS and then stored in a 30% sucrose solution for
at least 24 hours or until counted.

RNA extraction
All surfaces were sprayed with RNase-ZAP (Qiagen Cat No./ID: 74106) prior to extraction.
All RNA extractions were performed using the Quiagen RNAeasy kit (Qiagen Cat No./ID: 74106).
A solution of 600µL b-Mercaptoethanol (Aldrich, Cat No./ID: M6250) in RLT buffer per sample
at a 1µL:100µL ratio of b-Mercaptoethanol and RLT buffer respectively was made and placed into
tubes. One heaping scoop of Zr0B10-RNA 1.0mmDia. RNase-Free Zirconium Oxide beads were
added to each tube. A small amount of villus scrapings or liver was added to the tubes and samples
were placed into the bullet blender for 4 minutes at speed 8. Samples were centrifuged at 14800
RPM for 3 minutes at 4˚C. The supernatant was then transferred to a new 1.5mL Eppendorf tube.
600µL of 70% ethanol or 50% ethanol was added to the villus samples and liver samples
respectively. The samples were mixed and then transferred to a column. The column was
centrifuged at 1100RPM for 1 minute until all the sample was passed through the column and the
flow through was discarded. 350µL of RW1 was added to the columns and the columns were
centrifuged for 1 min at 11000RPM. DNase solution was prepared by mixing 10µL of DNase with
70µL of RDD buffer. The DNase solution was applied to the column for 15 mins at room
temperature. 350µL of RW1 was added again to the columns and respun at 11000RPM for 1 min
at room temperature; the flow through was discarded. 500µL of RPE buffer was added to the
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columns and centrifuged for 1 min at 11000RPM; this step was repeated once more. A new 2mL
collection tube was placed under the columns and columns were spun for 2 mins at 14800rpm to
dry. The columns were then placed into a fresh 1.5mL Eppendorf tube and 40µL of RNase free
water was added to each column and left for one minute. Columns were then spun for 1 min at
11000rpm to elute the RNA. Samples were immediately placed on ice and then RNA
concentrations and purity were determined using the NanoDrop One Spectrophotometer
(ThermoScientific).

cDNA Synthesis
cDNA synthesis was performed using 0.25-1µg of RNA per 20µL reaction following the
IScript protocol. RT-qPCR was performed for BMAL1 and GAPDH using the following primers:
Table 1.3: Primers used for qPCR to confirm CKO
TARGET
FORWARD PRIMER (5’à3’)
REVERSE PRIMER (5’à3’)
BMAL1
TGACCCTCATGGAAGGTTAGAA GGACATTGCATTGCATGTTGG
GAPDH
AGGTCGGTGTGAACGGATTTG
TGTAGACCATGTAGTTGAGGTCA

RT-qPCR was performed in 10µL reactions using a 384 well plate. Each reaction consisted of 5µL
of 2X QuantiIect SYBR Green, 3.2µL of RNase free water, 0.4µL of the forward primer, 0.4µL
of the reverse primer and 1µL of cDNA. Each gene was repeated in triplicate for each sample. The
plates were sealed and quantified using the Viia7 Real-Time PCR system (Thermo Fisher Scientific).

Tumour Quantification
Intestines were pinned to a Sylgard Plate and the entire length of the intestine was measured
and this value was divided by 4 to determine the length of each quarter of intestine. Adenomas
were counted in each quarter of the intestine using a Zeiss stereoscope at 2.5X magnification.
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Tumour size was determined to be either smaller than 1mm or equal/larger than 1mm using a 1mm
capillary tube as reference. After counting, the tissue sections were immediately Swiss rolled from
proximal (most interior) to distal (most exterior) region, a 25-gauge needle was inserted through
the roll to hold the shape and the tissue was placed back into 30% sucrose in 4˚C fridge for at least
2hours or up to 24hours. The needled rolls were then placed into cold Optimal Cutting Temperature
(OCT) compound and allowed to equilibrate for 1 hour. The needles were then removed, and the
rolls were then placed in the -80˚C freezer until sectioned.

Immunofluorescence (IF)
Swiss rolled, OCT mounted intestine samples were taken out of the -80˚C freezer and
placed in the -20˚C freezer to equilibrate overnight. The samples were then cryo-sectioned using
a cryostat and sectioned at 10µm. Samples were allowed to dry for 1 hour before being stored at 20˚C.
The sectioned slides were removed from the -20˚C freezer and allowed to thaw for 30
minutes. Slides were washed 3 times for 5 minutes in 1XPhosphate Buffered Saline (PBS)
followed by antigen retrieval if necessary (see Table 1.4 for antibodies and the appropriate antigen
retrieval method). Samples were washed 3 times for 5 minutes in 1XPBS and the tissue sections
were outlined using a hydrophobic pen. The slides were then placed in a humidity chamber and
blocked for 1 hour with 5% Normal goat serum (NGS) in 0.03% PBST (30µg of FAB IgG was
added during the blocking step if the primary antibody was mouse anti-mouse). Primary antibodies
were diluted to their appropriate concentrations in 1.2% NGS in 0.03% PBST, placed on the
sample and left overnight at 4˚C (see Table 1.2 for concentrations used). The slides were then
washed 3 times for 5 minutes in 1XPBS. Appropriate secondary antibody and DAPI were diluted

22

in 1.2% NGS in 0.03% PBST at a 1:2000 and 1:5000 concentration respectively and left at room
temperature for 2 hours. Samples were washed 3 times for 5 minutes in 1XPBS. Coverslips were
then mounted using ProLong gold antifade reagent (Invitrogen). Slides were then scanned and
analyzed using the Axioscan.

Colourometric Staining/Immunohistochemistry (IHC)
Previously sectioned slides were removed from the -20ºC freezer and allowed 30 minutes
to thaw. Slides were washed 3 times 5 minutes in 1XPBS followed by antigen retrieval (see Table
1.4 for antibodies used and antigen retrieval protocol if necessary). Samples were washed again 3
times in 1XPBS for 5 minutes and then outlined using a hydrophobic pen. All reagents used
henceforth are from the HRP/DAB (ABC) Detection IHC kit specific for rabbit (Abcam 64261) or
mouse (Abcam 64259) antibodies. The slides were placed in a humidity chamber and covered with
a hydrogen peroxide blocking solution for 10 minutes at room temperature then washed 2 times
for 5 minutes in 1XPBS. Slides were incubated with a protein block solution for 30 minutes at
room temperature in a humidity chamber followed by a 5 minute wash in 1XPBS. Primary
antibody was diluted in 1.2% NGS in 0.03% PBST, placed on the slide and allowed to incubate
over night at 4ºC in a humidity chamber. The next day, slides were rinsed 4 times in 1XPBS.
Streptavidin peroxidase solution was applied to the slides for 10 minutes at room temperature in a
humidity chamber. The slides were then rinsed 4 times using 1XPBS. One drop of DAB
chromogen to 50 drops of DAB substrate and mixed then applied to tissue for 5-10 minutes. Slides
were rinsed 4 times in 1XPBS followed by a rinse with dH2O. Slides were counterstained by
dipping in Hematoxylin for 10 seconds then washed in running water for 5 minutes. Slides were
incubated in acid alcohol for 10 seconds followed by a 1-minute wash in 0.1% Sodium Bicarbonate
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solution. They were then washed for 5 minutes in running water then placed in dH2O for 30
seconds. Slides were then dehydrated 2 times in 95% ethanol for 2 minutes at room temperature
followed by 2 times 100% ethanol for 2 minutes at room temperature. Slides were placed in HistoClear two times for 10 minutes at room temperature. Two drops of Clearium mounting medium
were placed on the slide and covered using a cover slip. Slides were scanned and analyzed using
the Axioscan.

Table 1.4: Antibody details used for IHC and IF
DILUTION

TYPE
OF ANTIGEN
STAINING
RETRIEVAL

RB
ANTI- Ab9535
MYELOPEROXIDASE

1:50

IHC (DAB)

N/A

RB
ANTI-BETA- Ab32572
CATENIN

1:250

IHC (DAB)

85ºC
sodium
citrate for 30
min

MS ANTI-REV-ERB

H00009572

1:250

IF

95ºC
sodium
citrate for 30
min

2º ANTIBODY

CATALOG
NUMBER

DILUTION

TYPE
OF
STAINING
IF
IF
IF

1º ANTIBODY

CATALOG
NUMBER

GT ANTI-MOUSE 594
GT ANTI-RABBIT 488
DAPI

1:2000
1:2000
1:5000

Quantification of IF, H&E and IHC samples
REV-ERB
The percentage of cells with nuclear REV-ERB staining were counted from ten distal crypts per
animal and there were 3 animals per genotype (Fig. 2.1B) (n=3). The percentage of cells with
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nuclear REV-ERB within adenomas were counted in 2-3 distal tumours per animal with 3 animals
per genotype (Fig. 2.2B) (n=3).
Crypt Morphology
Crypt length was measured using 20 crypts in each intestinal region for each animal with 3 animals
per genotype (Fig. 2.3A-D) (n=3). Crypt density was measured using 3X1mm segments per region
for each animal with 6 animals counted for each genotype (Fig. 2.3E-H) (n=6).
Wnt Signaling
For 𝛽-catenin high cell counts, the number of cells with both cytoplasmic and nuclear 𝛽-catenin
staining was counted in 10-15 crypts in each region for each animal with 3 animals per genotype
(Fig. 2.4B-D) (n=3). The same crypts were used to quantify 𝛽-catenin nuclear cells where all cells
with nuclear 𝛽-catenin are counted (Fig. 2.4E-G) (n=3).
Myeoloperoxidase (MPO)
The number of MPO positively stained cells were counted in the area from the base of the villi to
the underlying muscle layer in healthy tissue. 10 of these areas were counted in each intestinal
region per animal with 3 animals counted for APCmin/+; BMAL1+/+ (n=3) and 4 animals counted
for APCmin/+; BMAL1-/- (n=4); each data point represents the average number of neutrophils for
each animal. Using the same animals, the number of MPO positive cells were counted in individual
tumours in each intestinal region with roughly 1-3 tumours in each region counted per animal;
each data point represents an individual tumour counted.
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Statistics:
Statistical analysis was carried out using a two-way analysis of variance (ANOVA) to
compare differences in both genotype and time (Figures 2.1B, 2.2B). Student’s t-test was
performed to compare differences between genotypes (Figures 2.3A-H, 2.4B-G, 2.5B-D, 2.6B-D,
3.1A-B, 3.2A-D, F-M, 3.3A-D, F-M). Results are reported as mean ± SEM and statistical analysis
was performed using Prism (GraphPad); n refers to number of animals examined.
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Chapter 2: Characterization of intestinal
tissue in BMAL1 knockout mice
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Previous work done in the lab had shown that the conventional KO of BMAL1 in APCmin/+
mice resulted in an almost 2-fold increase in intestinal tumour incidence suggesting that the
circadian clock is able to supress tumourigenesis in tumour prone animals. However, the
mechanism in which this is occurring is unclear. Immunofluorescence and immunohistochemistry
were used to characterize: 1. Circadian clock activity in the intestine and corresponding tumours,
2. Cell production and Wnt signaling, and 3. Inflammation.

Circadian clock activity in intestinal epithelium and intestinal tumours

Some tumour cells have been shown to require circadian clock function to progress
whereas other studies have provided evidence to support the dysregulation of the clock increases
cancer risk42,49. This appears to be tissue specific, so it was important to assess the circadian clock
activity in the context of intestinal epithelium for this study. Previous work done in the lab
analyzed healthy intestinal tissue and tumourous tissue for clock gene mRNA expression and
found that intestinal tumours from BMAL1+/+ mice do have circadian rhythms in clock gene mRNA
expression but have a dampened amplitude. However, to further assess circadian clock activity at
the translational level, intestinal tissue sections from APCmin/+; BMAL1+/+ and APCmin/+; BMAL1/-

mice were stained using immunofluorescence with an antibody for REV-ERB protein, a

transcriptional target and negative regulator of BMAL1 and a component of the secondary loop of
the clock. Additionally, REV-ERB was analyzed due to its proposed anti-autophagy mechanism
that has been shown to inhibit tumour growth44,45.
Initially, ZT20 (3am) slides were analyzed as this was the time at which I predicted REVERB protein would be highest due to Malika’s previous work’s REV-ERB mRNA rhythms.
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Immediately, at ZT20, it was noted that REV-ERB protein was mainly localized to the nucleus of
intestinal epithelial cells, with little to no cytoplasmic staining. After staining the additional two
time points, ZT4 (11am) and ZT12 (7pm), the APCmin/+; BMAL1+/+ samples showed varying
intensity and localization of REV-ERB. Therefore, in an attempt to quantify and compare the
variation between APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/- mice, the percentage of REV-ERB
positive nuclei per crypt in healthy intestinal tissue were counted in the distal portion of the
intestine in both genotypes. Results show that REV-ERB protein in APCmin/+; BMAL1+/+ mice is
rhythmic, with 42.5±3.0% of crypt cells displaying nuclear REV-ERB at ZT4 (11am), 5.5±1.1%
of crypt cells with nuclear REV-ERB at ZT12 (7pm) and 97.3±0.97% of cells with nuclear REVERB at ZT20 (3am) (Figure 2.1A, B). It is also important to note that all epithelial cells in the
crypts display this changing abundance of REV-ERB protein (Figure 2.1A). When BMAL1 is
mutated and non-functional in the APCmin/+; BMAL1-/- mice, this drastic rhythmic change is lost
and REV-ERB nuclear expression remains constant (Figure 2.1A) with ZT4 having 92.6±1.5%
cells with nuclear REV-ERB, ZT12 with 93.0±1.4% and ZT20 with 98.8±0.36% nuclear REVERB (Figure 2.1B). Therefore, these data show the loss of BMAL1 results in a loss in rhythmic
REV-ERB protein expression.
Next, the circadian status of intestinal tumours was investigated using the same staining
and nuclear quantification method. The intestinal tumours in APCmin/+; BMAL1+/+ mice followed
a similar REV-ERB protein expression pattern to healthy intestinal tissue (Figure 2.2A) with
68.6±4.1% of the cells containing nuclear REV-ERB at ZT4 (11am), 6.6±2.2% at ZT12 (7pm) and
98.4± 1.3% of cells with nuclear REV-ERB at ZT20 (3am) (Figure 2.2B). Similar to healthy
crypts, the loss of BMAL1 in the APCmin/+; BMAL1-/- tumours results in the loss of rhythmic REVERB protein expression; nearly all epithelial cells in the tumours contain nuclear REV-ERB at
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each time point with 82.3±3.9% of cells having nuclear REV-ERB at ZT4, 85.8±3.8% at ZT12
and 97.9±0.93% at ZT20 (Figure 2.2B). Together, the data supports the conclusion that all
intestinal epithelial crypt and tumour cells display diurnal rhythms in REV-ERB at the translational
level in vivo and these rhythms are lost in both crypts and tumours when BMAL1 is absent.
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Figure 2.1: REV-ERB protein expression in ileal intestinal crypts of APCmin/+; BMAL1+/+ and
APCmin/+; BMAL1-/- mice. A) Representative images of immunofluorescent staining showing a
single intestinal crypt, outlined with white dotted line, at three time points ZT4 (11am), ZT12
(7pm) and ZT20 (3am) in APCmin/+; BMAL1+/+ (left 3 panels) and APCmin/+; BMAL1-/- (right three
panels) mice (Scale bar= 25µm). B) Percentage of REV-ERB positive nuclei per intestinal crypt
at the three timepoints (ZT4, ZT12 and ZT20) in APCmin/+; BMAL1+/+ mice (grey) and APCmin/+;
BMAL1-/- mice (red). (ANOVA F(2, 174)=363.9, p<0.0001).
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Figure 2.2: REV-ERB protein expression in ileal intestinal tumours of APCmin/+; BMAL1+/+
and APCmin/+; BMAL1-/- mice. A) Representative images of immunofluorescent staining showing
a region of tumourous intestinal tissue at three time points, ZT4 (11am), ZT12 (7pm) and ZT20
(3am), in APCmin/+; BMAL1+/+ (left 3 panels) and APCmin/+; BMAL1-/- (right three panels) mice
(Scale bar= 50µm). B) Percentage of REV-ERB positive nuclei per tumourous intestinal crypt at
the three timepoints (ZT4, ZT12 and ZT20) in APCmin/+; BMAL1+/+ mice (grey) and APCmin/+;
BMAL1-/- mice (red) (ANOVA F(2, 41)=96.71, p<0.0001).
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Intestinal Cell Production and Wnt Signaling
Intestinal tumours are thought to arise from ISCs or other intestinal precursor cells located
in the crypts58. Under homeostatic conditions, these progenitor cells respond primarily to Wnt
signaling, provided by both crypt Paneth cells and surrounding telocytes18, to initiate proliferation.
Recently it was proposed that the Wnt ligand is rhythmically secreted by differentiated Paneth
cells located at the base of the crypt in a circadian clock dependent manner59. If Wnt signaling is
a circadian clock-controlled pathway, loss of BMAL1 could disrupt this pathway possibly altering
intestinal tissue dynamics and cell turnover which in turn could contribute to the two-fold increase
in tumours observed in the APCmin/+; BMAL1-/- mice.
The ISCs underlie all epithelial cell production in the intestine. They respond to Wnt
signaling causing them to divide and as they are pushed out of the ISC niche of the crypts, they
then differentiate into all intestinal epithelial cells16. Therefore, abnormalities in Wnt signaling
within ISCs could result in changes to cellular turnover. To test cell production in the intestine,
crypt morphology was analyzed through crypt length and crypt density measurements throughout
the length of the intestine as crypt hyperplasia is indicative of increased cellular turnover and
proliferation61. The intestine samples were split into 3 regions: Proximal (closest to the stomach,
contains duodenum and jejunum), Medial (jejunum) and Distal (closest to the large intestine,
contains jejunum and ileum). There was no significant difference in crypt length between
APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/- mice in any of the intestinal regions (Figure 2.3A)
although, APCmin/+; BMAL1-/- trended toward smaller crypts. However, the average crypt length
from all regions of the intestine was not significantly different between genotypes (Figure 2.3D).
Next, crypt density was examined by counting the number of crypts present per 1mm segments
throughout the intestine. Again, the APCmin/+; BMAL1-/- mice trended toward decreased number of
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crypts with significantly less in the medial section (Figure 2.3E-F) and the average crypt density
throughout the entire intestine was significantly less in APCmin/+; BMAL1-/- mice. Therefore, the
crypt length and density data suggest APCmin/+; BMAL1-/- mice exhibit a slight decrease in cellular
turnover.
Since there is evidence for a slight decrease in cellular turnover in the APCmin/+; BMAL1-/mice, this could be due to a change in stem cell function, possibly through changes in Wnt
signaling since it is the main proliferative signal in the intestine during homeostasis. Therefore,
Wnt signaling was analyzed by staining for 𝛽-catenin, the main transcription factor responsible
for activating Wnt target genes used for ISC maintenance and proliferation. Samples were stained
at ZT12 (7pm) therefore results are only representative of the intestine at this particular time. The
𝛽-catenin staining (Figure 2.4A) was quantified using two different methods. First, the number of
𝛽-catenin “high” cells were counted per crypt. This refers to cells with both high nuclear and
cytoplasmic 𝛽-catenin staining; this quantification technique accounts for primarily only ISCs as
these are the cells that are responding to the Wnt ligand, accumulating 𝛽-catenin in the cytoplasm
where it then moves into the nucleus to turn on the transcription of Wnt target genes62. There was
no significant difference in the number of 𝛽-catenin high cells between APCmin/+; BMAL1+/+ and
APCmin/+; BMAL1-/- in any region of the intestine (Figure 2.4B-D). Additionally, the number of
nuclear stained 𝛽-catenin cells per crypt were also counted; this quantification accounts for both
ISCs as well as Paneth cells. Paneth cells have been shown to have higher nuclear 𝛽-catenin than
other intestinal epithelial cells and Wnt is also involved in the maturation of Paneth cells63. Again,
there were no significant differences in the number of 𝛽-catenin nuclear cells between APCmin/+;
BMAL1+/+ and APCmin/+; BMAL1-/- mice in any region of the intestine (Figure 2.4E-G). These
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data suggest the loss of BMAL1 in APCmin/+ mice does not affect Wnt signaling in the intestinal
epithelium at ZT12.
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Figure 2.3: Intestinal crypt morphology in APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/- mice.
Intestinal crypt length in µm in APCmin/+; BMAL1+/+ (grey) and APCmin/+; BMAL1-/- (red) mice in
A) proximal small intestine, B) medial small intestine, C) distal small intestine and D) average
crypt length from all regions. Intestinal crypt density per 1mm segment of intestine in APCmin/+;
BMAL1+/+ (grey) and APCmin/+; BMAL1-/- (red) mice in E) proximal small intestine, F) medial
small intestine, G) distal small intestine, and H) average crypt density from all regions. (Student’s
t-test: *p<0.05).
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Figure 2.4: 𝜷-catenin high and nuclear cells per intestinal crypt in APCmin/+; BMAL1+/+ and
APCmin/+; BMAL1-/- mice. A) Representative images of colourimetric staining of 𝛽-catenin in
intestinal crypts from mice at ZT12 (Scale bar= 50µm). Graphs depicting the number of cells with
both nuclear and cytoplasmic 𝛽-catenin staining per intestinal crypt in APCmin/+; BMAL1+/+ (grey)
and APCmin/+; BMAL1-/- (red) mice in the B) proximal small intestine, C) medial small intestine
and D) distal small intestine. Graphs depicting the number of all cells with nuclear 𝛽-catenin
staining in E) proximal small intestine, F) medial small intestine and G) distal small intestine.
(Student’s t-test: ns).
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Inflammation
Inflammation is thought to be circadian clock-controlled process. Epidemiological studies
have suggested individuals undergoing shift work are at a higher risk for both inflammatory bowel
diseases (IBD) and colorectal cancers27. Inflammation in the intestine exposes cells to superoxide
radicals released from leukocytes and this increased oxidative stress can induce DNA damage
increasing the risk of DNA mutations3. Additionally, cytokines secreted by immune cells can
directly signal tissue cells to proliferate37. Accordingly, patients with IBD are more prone to
developing intestinal and colorectal tumours64. To examine inflammation in the intestine, staining
for myeloperoxidase, a marker of neutrophils which are one of the major sources of free radicals
in the inflammatory response, was performed on APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/mice at ZT4 (11am) (Figure 2.5A). The number of positively stained cells per mm2 of intestinal
tissue was counted in the region from the base of the villi to the underlying muscle layer as this is
the area where the ISCs and intestinal precursor cells reside, and they are the cells in which most
intestinal tumours arise from58. The intestine samples, again, were split into Proximal, Medial and
Distal. There was no significant difference in the abundance of neutrophils between genotypes in
any region of the intestine (Figure 2.5B-D).
Inflammation was also assessed in the intestinal tumours of APCmin/+; BMAL1+/+ and
APCmin/+; BMAL1-/- mice (Figure 2.6A). The number of positively stained neutrophils per region
of tumour from each individual mouse was counted. Only one sample from the APCmin/+;
BMAL1+/+ group had countable tumours in the proximal section due to inconsistent staining in the
tumours and the fact that APCmin/+; BMAL1+/+ mice do not have very many tumours in the proximal
region, therefore the 3 datapoints are only from one individual mouse. Again, there was no
significant difference in the abundance of neutrophils in the tumours between genotypes in any
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region of the intestine (Figure 2.6B-D). These data suggest that loss of BMAL1 does not affect the
abundance of neutrophils in the intestine or intestinal tumours at ZT4.
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Figure 2.5: Neutrophil abundance in healthy intestinal tissue in APCmin/+; BMAL1+/+ and
APCmin/+; BMAL1-/- mice. A) Representative images of colorimetric staining for neutrophils in
healthy intestinal tissue in APCmin/+; BMAL1+/+ mice (left) and APCmin/+; BMAL1-/- mice (right) at
ZT4. Arrows indicate example of stained neutrophils (Scale bar= 50µm). Quantification of number
of neutrophils per mm2 of intestinal tissue surrounding the crypts in APCmin/+; BMAL1+/+ (grey)
and APCmin/+; BMAL1-/- (red) mice in B) proximal small intestine, C) medial small intestine and
D) distal small intestine. (Student’s t-test: ns).
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Figure 2.6: Neutrophil abundance in tumourous intestinal tissue in APCmin/+; BMAL1+/+ and
APCmin/+; BMAL1-/- mice. A) Representative images of colorimetric staining for neutrophils in
tumourous intestinal tissue in APCmin/+; BMAL1+/+ mice (left) and APCmin/+; BMAL1-/- mice (right)
from ZT4. Arrows indicate example of stained neutrophils (Scale bar= 50µm). Quantification of
number of neutrophils per area of tumour in APCmin/+; BMAL1+/+ (grey) and APCmin/+; BMAL1-/(red) mice in B) proximal small intestine, C) medial small intestine and D) distal small intestine.
(Student’s t-test: ns).
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Chapter 3: The role of the intestinal
circadian clock in intestinal tumour incidence
and progression
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The 2-fold increase in intestinal tumourigenesis observed in the APCmin/+; BMAL1-/- mice
could be due to an intestinal intrinsic mechanism, a systemic mechanism, such as inflammation,
or a combination of both. In the last chapter, a few tissue intrinsic and extrinsic factors were
evaluated in APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/- mice. However, in this particular KO
of BMAL1, every cell within the mouse is deficient for this core clock gene which makes it quite
difficult to completely distinguish between systemic and tissue specific effects as many aspects of
the animal’s biology and behaviour could be affected. In order to dissect the role the intestinal
clock specifically plays in tumourigenesis, a conditional knockout (CKO) of BMAL1 in only the
intestinal epithelium of mice was made. The Cre-lox system was utilized to achieve this. Mice
with a Cre-recombinase gene conjugated to a Villin promoter (VilCre/+ mice), a gene only expressed
in the epithelium of the digestive tract, were crossed to mice with exon 8 of the BMAL1 gene
flanked by loxp sites (BMAL1fl/fl mice). The Cre-Recombinase, now only expressed in the intestinal
epithelium, is able to recognize the loxp sites and excise the region within, specifically exon 8 of
BMAL1 which is the DNA binding domain, thereby eliminating the transcriptional activity of
BMAL1. These mice were then crossed onto an APCmin/+ background resulting in a strain of mice
predisposed to intestinal neoplasia that have a functioning circadian clock in every tissue of the
body except for the intestinal epithelium.
In order to confirm the CKO of BMAL1 was occurring specifically in the intestine, control
mice lacking the Cre-recombinase gene and CKO mice were dissected and analyzed for mRNA
expression of BMAL1 in both liver and villus scraping samples using RT-qPCR. In both the control
mice (Vil+/+; BMAL1fl/fl) and the CKO animals (VilCre/+; BMAL1fl/fl) there is comparable BMAL1
mRNA expression relative to GAPDH in the liver (Figure 3.1A); however, in the villus scrapings,
where intestinal epithelium was sampled, the control (Vil+/+; BMAL1fl/fl) mice continue to express
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BMAL1 whereas it’s expression is completely absent in the CKO (VilCre/+; BMAL1fl/fl) animals
(Figure 3.1B). This confirms the knockout of BMAL1 is occurring specifically in the intestinal
epithelium and is unaffected in tissues of the body where Villin is not expressed.
After confirming the CKO was occurring, the control (APCmin/+; Vil+/+; BMAL1fl/fl) and
experimental mice (APCmin/+; VilCre/+; BMAL1fl/fl) were evaluated for tumour incidence, looking
specifically at size and location of tumours. The two groups were dissected at 3 months of age,
consistent with the age at which the original BMAL1 KO animals were collected. The intestine was
measured and divided into 4 regions: Proximal, Medial 1, Medial 2 and Distal in order to assess
the distribution of tumours throughout the intestine; the two medial sections have been combined
in Figure 3.2 and 3.3 to be consistent with nomenclature from Chapter 2 figures. Additionally,
tumours were categorized as either smaller than 1mm and larger than 1mm using a 1mm capillary
tube as a reference; this was done as a crude evaluation of tumour progression.
The control animals and CKO animals displayed a similar trend in distribution of intestinal
tumours in both small (<1mm) and large (>1mm) tumours; an increase in the number of <1mm
tumours moving further through the intestine with highest in the medial section (Figure 3.2A-C)
and an increase in the number of >1mm tumours moving through the intestine with the highest in
the distal region (Figure 3.3A-C) which is similar to the trends seen in the original BMAL1 KO.
Interestingly, the CKO animals consistently had more <1mm tumours in each region of the
intestine compared to controls with significant differences in the proximal and medial section
(Figure 3.2A, C) but the number of >1mm tumours was equivalent in all regions (Figure 3.3 AD). Cumulatively, the number of <1mm tumours in the CKO was significantly higher than their
control littermates (Figure 3.2D). This data indicates that the loss of the circadian clock in the
intestinal epithelium is mainly responsible for supressing tumour initiation as evident by increased
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number of small tumours in the BMAL1 CKO whereas tumour progression is unaffected since both
control and CKO animals had equivalent number of large tumours.
Previous observations using the original KO of BMAL1 showed a significant difference in
both small (<1mm) and large (>1mm) tumours with the latter not recapitulated in the CKO mice.
Work performed from a PhD student from our lab, observed increased numbers of CD45 positive
cells, a general immune cell marker, in the intestine of the APCmin/+; BMAL1-/- mice (unpublished
data). Therefore, there is evidence that our BMAL1 KO mice have increased inflammation in the
intestine. This elevated inflammation could result in increased cytokine production, which is able
to directly promote intestinal cell proliferation37, potentially contributing to the increased tumour
growth observed in the BMAL1 KO animals. Moreover, in the BMAL1 KO animals, every cell
lacks a functioning circadian clock, including immune cells, which could be the source of this
differing abundance, whereas in the BMAL1 CKO mice, where only the intestine does not have a
functioning circadian clock, the immune system should be unaffected. Therefore, in an attempt to
mimic the complete BMAL1 KO phenotype in the CKO animals, the CKO mice were subjected to
chronic intestinal inflammation to assess systemic effects of inflammation on tumour number and
size as chronic inflammation is also known to increase risk of colorectal cancers64. This experiment
was done as part of a related IBD project conducted by a PhD student in our lab, Zainab Taleb,
where she performed and monitored the DSS treatment and my work was only to quantify the
intestinal tumours that arose. At 5-6 weeks of age, control mice (APCmin/+; Vil+/+; BMAL1fl/fl) and
experimental mice (APCmin/+; VilCre/+; BMAL1fl/fl) were given 3 rounds of 7 day 2% Dextran
Sodium Sulphate (DSS) or 3% DSS through their drinking water with each round followed by a
10 day recovery period (Figure 3.2E, 3.3E). Two concentrations of DSS were used to determine
if tumour induction and progression was DSS dosage dependent. DSS is a chemical that disrupts
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the intestinal epithelium allowing bacteria to penetrate into the submucosal layer inducing an acute
inflammatory response65. This experimental method is widely used to mimic inflammatory colitis
in mice. By the end of the treatments, all mice were ~3 months of age to be consistent with the
previous experiments.
All control and CKO mice subjected to this experiment survived the DSS treatments
suggesting the conditional loss of the clock in the intestinal epithelium does not increase life
threatening inflammatory responses. After the last 10-day recovery period, mice were dissected
and the tumours in the small intestine were counted using the same method previously described.
The 2% DSS and 3% DSS treated control animals had significantly more total tumours <1mm than
the undamaged controls (student’s t-test: p=0.0048 and p=0.0156 respectively) demonstrating the
DSS is able to affect the small intestine and increase tumour number. In the 2% DSS treated group,
the BMAL1 CKO mice had significantly more <1mm tumours in the proximal region of the
intestine (Figure 3.2F) but no difference in the medial or distal regions (Figure 3.2G, H);
cumulatively, the 2% DSS treated CKO mice, again, had significantly more total tumours <1mm
compared to their controls. The effect of DSS appears to plateau at 2% as there is no longer a
significant difference in the number of <1mm tumours in the 3% DSS treated CKO mice compared
to the 3% DSS controls (Figure 3.2J-M). Unfortunately, the number of >1mm tumours remained
relatively the same under both 2% and 3% DSS treatment (Figure 3.3 G-M) with the exception of
a decrease in >1mm tumour number in the proximal region of the 2% DSS treated CKO mice
(Figure 3.3 F). This indicates that prolonged DSS-induced inflammation is unable to increase
tumour growth in BMAL1 CKO mice and is only able to increase tumour initiation regardless of
genotype. Collectively, these data suggest the loss of the intestinal circadian clock drives tumour
number, not growth, with or without inflammation.
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Figure 3.1: Confirmation of CKO of BMAL1 in intestinal epithelium. There was no
difference in BMAL1 mRNA expression relative to GAPDH in A) liver samples. There was
expression of BMAL1 in B) villus scrapings samples in wildtype (grey) mice but no expression
of BMAL1 in CKO mice (red). (Student’s T-test: ****, p<0.0001)
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Figure 3.2: Number of small (<1mm) tumours in undamaged and DSS treated CKO mice.
The number of <1mm tumours in APCmin/+; Vil+/+; BMAL1fl/fl mice (grey) and APCmin/+; VilCre/+;
BMAL1fl/fl (red) in: untreated A) proximal small intestine, B) medial 1 and medial 2 sections of
the small intestine, C) distal small intestine and D) the total number of tumours <1mm
throughout the entire small intestine. E) Prolonged inflammation was achieved through three
rounds of DSS (either 2% or 3%) with each round followed by a 10-day recovery period. The
number of <1mm tumours in 2% DSS treated mice in F) proximal small intestine, G) medial 1
and medial 2 sections of the small intestine, H) distal small intestine and I) total number of
<1mm tumours throughout the entire small intestine. The number of <1mm tumours in 3% DSS
treated mice in J) proximal small intestine, K) medial 1 and medial 2 sections of the small
intestine, L) distal small intestine and M) total number of <1mm tumours throughout the entire
small intestine. (Student’s t-test: *p<0.05, **p<0.01, ***p<0.001).
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Figure 3.3: Number of large (>1mm) tumours in undamaged and DSS treated CKO mice. A)
The number of >1mm tumours in APCmin/+; Vil+/+; BMAL1fl/fl mice (grey) and APCmin/+; VilCre/+;
BMAL1fl/fl (red) in: untreated A) proximal small intestine, B) medial 1 and medial 2 sections of the
small intestine, C) distal small intestine and D) the total number of tumours >1mm throughout the
entire small intestine. E) Prolonged inflammation was achieved through three rounds of DSS
(either 2% or 3%) with each round followed by a 10-day recovery period. The number of >1mm
tumours in 2% DSS treated mice in F) proximal small intestine, G) medial 1 and medial 2 sections
of the small intestine, H) distal small intestine and I) total number of >1mm tumours throughout
the entire small intestine. The number of >1mm tumours in 3% DSS treated mice in J) proximal
small intestine, K) medial 1 and medial 2 sections of the small intestine, L) distal small intestine
and M) total number of >1mm tumours throughout the entire small intestine. (Student’s t-test:
*p<0.05).
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Chapter 4: Discussion and Future Directions
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The Earth’s rotation creates diurnal environmental changes. Organisms have adapted their
biological and behavioural processes to increase energy efficiency and overall fitness through the
evolution of the molecular circadian clock. The circadian clock’s contribution to cancer
development and progression has been a controversial and contending area of research as some
studies provide evidence for the requirement of the clock in tumour progression whereas others
show loss of the clock increases cancer risk. The role of the circadian clock in specifically intestinal
tumourigenesis was addressed in this project. In my thesis I sought to: a) characterize intestinal
intrinsic and systemic mechanisms in BMAL1 KO mice and b) understand the role the intestinal
circadian clock specifically plays in intestinal tumourigenesis.

All crypt and tumour epithelial cells exhibit circadian rhythms in vivo
Various studies have examined the role of the circadian clock in tumourigenesis in other
tissues. Some finding cancer cells’ requirement for circadian clock function in order to progress49
while others demonstrate the disruption of the circadian clock increases cancer risk42. Previous
work performed in the lab showed that cancer-prone animals with a functioning circadian clock
(APCmin/+; BMAL1+/+) exhibit circadian rhythms in clock gene mRNA expression in healthy
intestinal tissue and I also observed rhythms in REV-ERB protein expression in healthy intestinal
tissue from the same APCmin/+; BMAL1+/+ mice. Additionally, previous work showed the mRNA
rhythms are retained in intestinal tumours of APCmin/+; BMAL1+/+ mice but are observed with a
dampened amplitude. I observed similar rhythms in REV-ERB protein expression in intestinal
tumours from APCmin/+; BMAL1+/+ mice. Antibody staining is advantageous as it gives information
regarding relative abundance of a protein, protein localization and which specific cells are
expressing the protein. It is important to note that from the immunofluorescence data, all intestinal
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epithelial crypt cells, including transit amplifying cells, ISCs and Paneth cells, exhibit rhythmic
REV-ERB protein expression. Furthermore, these rhythms in protein expression are absent in both
healthy and tumourous tissue when BMAL1 is mutated, as evident through consistent nuclear REVERB staining at every time point tested. If the circadian clock has evolved to increase the fitness
of cells and organisms, how are tumour cells able to proliferate at such high rates in the absence
of the circadian clock? Although we showed tumours display rhythmic transcription and
translation of circadian clock genes in BMAL1 wildtype animals in vivo, the mRNA rhythms are
not as robust. This could suggest that the tumour cells may simply mimic healthy tissue by
receiving signaling from adjacent tissue, aligning the rhythms to the rest of the body even though
these cells may not have autonomous circadian rhythms. However, when this signaling is lost,
such as in BMAL1 mutants, the cells lose the regulation of certain processes and can then
upregulate particular growth and division pathways allowing for increased tumour incidence.
BMAL1 is a positive transcriptional regulator of REV-ERB therefore, theoretically, one
would expect decreased levels of REV-ERB in the absence of BMAL1, however, the opposite was
observed in terms of protein expression in the BMAL1 mutant animals tested. There was stable
REV-ERB protein at all time points observed in the BMAL1 mutant animals. One explanation for
this could be that MYC may be compensating for loss of BMAL1’s transcriptional activation of
REV-ERB. MYC has a similar structure to BMAL1, as they both have a basic helix-loop-helix
DNA binding domain. Additionally, MYC has been shown to bind to E-boxes inducing REV-ERB
expression thereby disrupting circadian oscillations34. In intestinal tissue with high Wnt signaling
and thus increased c-MYC expression, this could be responsible for driving stable high levels of
REV-ERB production. Another possibility could be due to stability and localization of the protein.
The E3 ubiquitin ligase, SIAH2, has been shown to regulate REV-ERB protein degradation and
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mediates its circadian turnover66. SIAH2 colocalizes with the serine/threonine kinase, DYRK2, in
the cytoplasm where DYRK2 phosphorylates SIAH2 increasing its ubiquitination activity;
moreover, the phosphorylation status of SIAH2 results in differing cellular localization patterns67.
Because REV-ERB was primarily observed in only nuclear regions in the APCmin/+; BMAL1-/mutant mice, REV-ERB protein stability may be altered in the BMAL1 mutants preventing it from
exiting the nucleus and being degraded by SIAH2 in the cytoplasm. This is solely speculation and
further analysis would need to be conducted in order to dissect the relationship between BMAL1
loss and REV-ERB protein dynamics.
This data is also not fully supportive of the role of REV-ERB as a tumour suppressor.
Recently, REV-ERB has been proposed to inhibit tumour progression via an anti-autophagy
mechanism44,45. Autophagy is a process in which a cell is able to engulf, degrade and recycle
organelles, proteins and cytoplasm to accommodate metabolic demands and eliminate waste
buildup. Cancer cells have been shown to use this mechanism to circumvent senescence and meet
exceeding metabolic activity46. Additionally, REV-ERB agonists have shown significant promise
in preventing and reducing tumour growth without producing cytotoxic effects44,45. The BMAL1
mutants used in this thesis have moderate, stable levels of REV-ERB protein throughout the day
and still produce 2 times the number of tumours than BMAL1 wildtype animals who have
fluctuating REV-ERB levels. Again, this could be attributed to REV-ERB protein localization as
this proposed mechanism could be occurring in the cytoplasm although, the exact mechanism
between REV-ERB and autophagy has yet to be determined. Therefore, this data suggests REVERB does not act as a tumour suppressor in the intestinal epithelium.
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Intestinal Cell Production and Wnt Signalling
Intestinal tissue completely renews itself every 4-5 days17. The ISCs are crucial in
maintaining this high turnover of cells therefore cell production and stem cell maintenance is
essential for proper intestinal homeostasis. The main signalling pathway responsible for both stem
cell maintenance and proliferation in the intestine is the Wnt signalling pathway20. This pathway
has recently been suggested to be controlled by the circadian clock via cyclic secretion of Wnt3a
from differentiated Paneth cells in vitro/organoid culture59. From the data presented, there
appeared to be a mild reduction in tissue renewal when BMAL1 is absent as exemplified through
a slight decrease in crypt length and significant decrease in crypt density. This is consistent with
previously published data on clock mutant animals59,68. Additional tests to observe the ratio of
differentiated cells to proliferating cells would be beneficial in determining if differentiation or
proliferation is affected by BMAL1 loss. Using a Ki67 antibody, a marker of proliferating cells,
would show the proportions of these cells and changes to the number of positively stained cells or
length of the proliferation zone could provide insight into the balance between proliferation and
differentiation in these two genotypes.
If there is a change in tissue renewal and turnover, one would expect these changes to be a
result of abnormal stem cell signalling and/or function. However, 𝛽-catenin protein level and
localization showed no changes in nuclear localization or cells with this accumulated protein at
the time point tested (ZT12) suggesting loss of BMAL1 does not affect the Wnt pathway. As
previously mentioned, Wnt signaling has been proposed to be a circadian clock-controlled
mechanism in which Wnt is rhythmically secreted by Paneth cells in in vitro/organoid culture.
However, this observation has not been able to be replicated by other members of the lab, therefore
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at the time of experimentation for this project, only ZT12 was thought to be appropriate. RT-qPCR
analysis performed in a previous project by Malika Nunes observed diurnal changes in Wnt target
genes, such as c-MYC and AXIN2, in vivo in APCmin/+; BMAL1+/+ mice. The rhythmicity in Wnt
target genes observed in vivo but not replicated in vitro could be due many reasons. One possible
reason may be because differentiated Paneth cells are not the main contributor of Wnt secretion in
the intestine. Recent reports have shown that both Paneth cells and underlying telocytes, a type of
connective tissue cell, contribute to Wnt secretion and signaling18. When Wnt is removed from all
intestinal epithelial cells, these animals still exhibit normal crypt structure and stem cell function;
however, when Wnt secretion is inhibited in only the telocytes, this results in severe crypt collapse,
decrease in ISCs and impaired tissue turnover18. Since these stromal cells are indispensable in the
Wnt signaling pathway in the intestine, these cells may potentially be responsible for creating the
rhythmic Wnt target genes observed in vivo. These cells are absent in organoid culture where this
Wnt source is replaced by static Wnt-containing media. Again, this is speculation and further work
would need to be done to determine if stromal cells contribute to the rhythmic changes in Wnt
target gene expression. Ultimately, testing other time points would be advantageous to determine
if there are any changes in 𝛽-catenin accumulation throughout the day which is a limitation to the
work conducted for this thesis.

Inflammation
The circadian clock has been implicated in regulating intestinal inflammation35.
Additionally, intestinal inflammation is both a driver of regeneration and cancer initiation69. Shift
work individuals have higher prevalence of colitis and other inflammatory bowel diseases70;
additionally, those individuals with IBD and chronic intestinal inflammation are at higher risk for
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developing colorectal cancers64. Therefore, it was important to assess whether the BMAL1 mutants
had higher intestinal inflammation that could contribute to the 2-fold increase in tumour incidence.
Inflammation exposes surrounding cells to oxidative stress via production of free radicals which
have the potential to induce DNA damage3. Immune cells also produce inflammatory cytokines
which can stimulate cell proliferation37,69. When tested, the number of neutrophils, which are the
primary free radical-producing cells, in both untransformed tissue and intestinal tumours did not
change between APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/-.
Neutrophil tissue invasion occurs in a cyclic manner in multiple tissues of the body (ex.
liver, lung and skin) except for the intestine where they are observed at a relatively constant level71,
therefore, only one time point (ZT4) was thought to be appropriate. Although, there was no
difference in neutrophils in either healthy tissue or tumours at this time point, this is only one of
the many immune cells that could be present. Originally, multiple immune cell markers, such as
F4/80 which marks macrophages, were to be tested through immunohistochemistry but due to
antibodies not working in the tissue sections, they could not be included. However, Zainab Taleb,
a PhD student in the lab, did perform anti-CD45 staining, a general immune blood cell marker, in
the APCmin/+; BMAL1+/+ and APCmin/+; BMAL1-/- samples and observed higher abundance in the
BMAL1 mutant animals suggesting they do have increased inflammation. It would be important to
do more analysis on what types of blood cells are present in these BMAL1 mutants through the use
of immunohistochemistry or flow cytometry to determine if there is a specific cell type that is
elevated in the BMAL1 mutants. Also, a conditional knockout of the clock in blood cells could be
done on the APCmin/+ background to see if it is able to induce higher tumour incidence to further
demonstrate the loss of the clock in immune cells can increase the probability of tumour initiation
events.
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The intestinal epithelium clock is responsible for supressing tumour initiation
The APCmin/+; BMAL1-/- mice have a 2-fold increase in intestinal tumours indicating the
circadian clock plays a role in intestinal tumourigenesis. Nonetheless, it is unclear whether this is
a tissue specific mechanism, a systemic mechanism or a combination of both is disrupted when
BMAL1 is lost. Using the CKO of BMAL1 in only the intestinal epithelium, I attempted to
distinguish between the two. Tumour initiation is significantly higher in the BMAL1 CKO animals
compared to their wildtype littermates with the number of small (<1mm) tumours being
comparable to the original BMAL1 KO mice. However, the loss of the intestinal clock is not able
to fully recapitulate the tumour progression seen in the conventional BMAL1 KO since there were
no differences in large (>1mm) tumours between genotypes. Although this indicates the loss of
the intestinal clock is responsible for initiation of tumours, it does not seem to lead to faster growth
or progression.
In an attempt to reproduce the increased >1mm tumour phenotype from the BMAL1 KO in
the CKO mice, both control and CKO animals were subjected to DSS treatment to induce acute
inflammatory damage. In the 2% and 3% DSS treated mice, chronic DSS-induced intestinal
inflammation increased the overall number of <1mm tumours in both control and CKO animals
however, the number of >1mm tumours was unaffected. This suggests elevated levels of
inflammation is only able to increase the probability of tumour initiation events but it, too, is unable
to induce accelerated tumour growth. The two concentrations of DSS were used to determine
whether the original BMAL1 KO phenotype could be reproduced using higher concentrations of
DSS. However, the significance in the number of <1mm tumours is lost in the CKO mice under
the 3% DSS treatment. One potential reason for this loss may be due to differing consumption of
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2% and 3% DSS water by the mice as water intake was not monitored in this experiment. Another
possibility may be that the tissue is under such significant damage due to the high 3% DSS
concentration that it has reached somewhat of a regeneration limit and differences in regenerative
ability between the controls and CKO is no longer distinguishable. Regardless, in both the
undamaged and 2% DSS treated mice, the CKO mice had significantly more <1mm tumours than
their control littermates suggesting the intestinal circadian clock is able to suppress tumour
initiation in the intestine with or without inflammation.
The question now becomes what is the other contributing factor in the original BMAL1 KO
animals, which is absent in the CKO mice, that is contributing to the increased tumour growth?
The conventional KO of BMAL1 in mice disrupts all circadian aspects of their behaviour as well
as cellular and tissue processes and hormonal secretions. The KO of BMAL1 in mice has adverse
health concerns including reduced lifespan and premature aging. These mice have stunted growth,
accelerated muscle loss and increased levels of ROS which begin to display as early as 10 weeks
of age72. The mice sampled for the original BMAL1 KO were 3 months of age (12-14 weeks)
which, although it is prior to the onset of the majority of age-related phenotypes, still exhibit
increased levels of oxidative stress. BMAL1 has been shown to modulate the mammalian stress
response pathway with increased ROS levels in a variety of tissue cell types when BMAL1 is lost73–
75

. Previously, the idea of production of extracellular ROS as a by-product of inflammation was

addressed, however, intracellular management of ROS may be disrupted in the absence of BMAL1
as there is evidence to support loss of BMAL1 increases Reactive Oxygen Species Modulator 1
(ROMO1), a protein responsible for production of intracellular ROS, in epidermal tissue74. If this
mechanism is conserved in other tissues including intestinal epithelial cells and surrounding cells,
excessive intracellular ROS coupled with extracellular ROS could increase risk for DNA damage
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and mutations which could lead to abnormal or accelerated tumour growth. Furthermore, it may
be advantageous to assess ROS levels in the intestinal and surrounding tissue to see if there are
any notable differences between the KO and CKO animals as well as their DNA damage and stress
responses to see if this contributes to the differences in tumour growth phenotypes.
In terms of behavioural rhythms, BMAL1 mutant mice do not exhibit normal nocturnal
activity. This change in activity influences their eating patterns. In a tissue designed to absorb
nutrients, food is likely a strong entraining cue for the intestine. Additionally, the intestine houses
a wide variety of microbes that constitute the microbiota which aid in synthesizing essential
vitamins the host is unable to produce and contributes to the breakdown of non-digestible
substrates76. More importantly, the gut microbiota has been shown to have diurnal rhythms in
microbe abundance governed by daily feeding rhythms77; these microbiota rhythms are abolished
in circadian clock mutant mice as well as mice subjected to photoperiod disruption. The dysbiosis
disrupts various metabolic processes and was found to be transmissible via gut microbes through
fecal transplant77. Moreover, the microbiome has also been shown to influence intestinal tissue
rhythms by inducing rhythmic expression of histone deacetylase 3 (HDAC3) which, again, is able
to regulate metabolic rhythms in the intestinal cells78. Finally, these metabolic disruptions in
circadian clock deficient animals can be reverse through time-restricted feeding79. Therefore, the
KO of BMAL1 would disrupt eating behaviours thereby affecting metabolic processes that could
contribute to the increased tumour progression and growth observed.
The circadian clock is also known to regulate endocrine factors, including glucocorticoid
secretion which is able to synchronize peripheral clocks13,14. Additionally, growth hormone
production is closely associated with circadian rhythms and sleep patterns, peaking during the
biological resting phase. However, growth hormone surges do occur after the onset of sleep
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regardless of time of day sleep takes place80. BMAL1 mutants have abnormal sleep-wake cycles,
with no clear rest phase. This abnormal sleep-wake schedule, with irregularly spaced rest times,
could influence growth hormone production potentially contributing to the increased tumour
growth observed in our BMAL1 KO mice. Moreover, the hormone Ghrelin, that stimulates appetite
and increases in anticipation of habitual mealtimes, has also been suggested to modulate growth
hormone production81. In a human study, administration of intravenous Ghrelin was associated
with increased growth hormone levels. Again, in BMAL1 mutant animals with abnormal sleepwake cycles and eating patterns, anticipatory Ghrelin release could be altered potentially
increasing growth hormone levels contributing to increased tumour growth82. Analyzing hormone
levels in the APCmin/+; BMAL1-/- mice may be beneficial to provide insight into this potential
tumour growth contributing factor.

Conclusion
In this study, I was able to establish that the intestinal epithelial crypt cells and epithelial
tumour cells exhibit circadian rhythms at the translational level in mice with a functioning
circadian clock. Additionally, I found that the intestinal epithelial circadian clock alone is able to
supress tumour initiation with or without inflammation. The next steps for this project would most
likely include a conditional knock out of BMAL1 in the blood cells of APCmin/+ mice to assess if
loss of circadian function in the immune cells may contribute to intestinal tumourigenesis.
Additionally, it would be important to analyze the specific types of immune cells present in the
intestine as well as which cytokines are being produced. This could provide insight into how the
intestine may be responding to these inflammatory signals thereby contributing to difference in
tumourigenesis. Further work is therefore needed to establish a mechanism in which the circadian
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clock is able to inhibit tumour initiation and progression however, understanding the factors
contributing to colorectal cancer is important in preventing and diagnosing this disease, especially
in shift work individuals. Additionally, understanding potentially tumourigenic biological
mechanisms that are affected due to loss of clock function can provide insight into future cancer
treatment, including time-dependent treatment, for individuals with and without disrupted
circadian rhythms.
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